<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Telo Genomics Corp — News on 6ix</title>
    <link>https://6ix.com/company/telo-genomics-corp</link>
    <description>Latest news and press releases for Telo Genomics Corp on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 14 Apr 2026 11:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/telo-genomics-corp" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835f59678dffbe2df12f40c.webp</url>
      <title>Telo Genomics Corp</title>
      <link>https://6ix.com/company/telo-genomics-corp</link>
    </image>
    <item>
      <title>Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-genomics-announces-study-with-university-of-athens-to-advance-next-generation-mrd-risk-stratification-in-multiple-myeloma</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-genomics-announces-study-with-university-of-athens-to-advance-next-generation-mrd-risk-stratification-in-multiple-myeloma</guid>
      <pubDate>Tue, 14 Apr 2026 11:00:00 GMT</pubDate>
      <description>Clinical Trial Seeks to Validate Novel Blood-Based Assay that Predicts Relapse Risk by Analyzing ...</description>
    </item>
    <item>
      <title>Telo Genomics Announces Appointment of John Farlinger as CEO and Chairman</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-genomics-announces-appointment-of-john-farlinger-as-ceo-and-chairman</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-genomics-announces-appointment-of-john-farlinger-as-ceo-and-chairman</guid>
      <pubDate>Tue, 31 Mar 2026 11:00:00 GMT</pubDate>
      <description>Vancouver, British Columbia--(Newsfile Corp. - March 31, 2026) -  Telo Genomics Corp. (TSXV: TELO...</description>
    </item>
    <item>
      <title>Telo Genomics Closes Second and Final Tranche of Convertible Debentures Financing</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-genomics-closes-second-and-final-tranche-of-convertible-debentures-financing</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-genomics-closes-second-and-final-tranche-of-convertible-debentures-financing</guid>
      <pubDate>Mon, 09 Mar 2026 11:00:00 GMT</pubDate>
      <description>Vancouver, British Columbia--(Newsfile Corp. - March 9, 2026) -  Telo Genomics Corp. (TSXV: TELO)...</description>
    </item>
    <item>
      <title>Telo Genomics Corp. Announces Upsizing of Previously Announced Private Placement</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-genomics-corp-announces-upsizing-of-previously-announced-private-placement</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-genomics-corp-announces-upsizing-of-previously-announced-private-placement</guid>
      <pubDate>Fri, 27 Feb 2026 20:32:00 GMT</pubDate>
      <description>Vancouver, British Columbia--(Newsfile Corp. - February 27, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the &quot;Company&quot; or &quot;Telo Genomics&quot;), a leader in the development of diagnostic and prognostic tests for human disease through the analysis of chromosomal telomeres, is pleased to announce that it has increased the size of its previously announced non-brokered private placement of non-transferable secured convertible debentures (the &quot;Debentures&quot;) from up to $1,200,000 to up to...</description>
    </item>
    <item>
      <title>Telo Genomics Closes First Tranche of Convertible Debentures Financing</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-genomics-closes-first-tranche-of-convertible-debentures-financing</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-genomics-closes-first-tranche-of-convertible-debentures-financing</guid>
      <pubDate>Wed, 18 Feb 2026 12:00:00 GMT</pubDate>
      <description>THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES    OR FOR DISSEMINATION IN TH...</description>
    </item>
    <item>
      <title>Telo Genomics Announces Appointment of John Price as Chief Financial Officer</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-genomics-announces-appointment-of-john-price-as-chief-financial-officer</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-genomics-announces-appointment-of-john-price-as-chief-financial-officer</guid>
      <pubDate>Thu, 29 Jan 2026 13:00:00 GMT</pubDate>
      <description>Toronto, Ontario--(Newsfile Corp. - January 29, 2026) -  Telo Genomics Corp. (TSXV: TELO) (OTCQB:...</description>
    </item>
    <item>
      <title>Telo Genomics Announces Non-Brokered Private Placement of Convertible Debentures for up to $1,200,000</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-genomics-announces-non-brokered-private-placement-of-convertible-debentures-for-up-to-dollar1200000</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-genomics-announces-non-brokered-private-placement-of-convertible-debentures-for-up-to-dollar1200000</guid>
      <pubDate>Mon, 19 Jan 2026 13:00:00 GMT</pubDate>
      <description>THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES    OR FOR DISSEMINATION IN TH...</description>
    </item>
    <item>
      <title>Telo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-genomics-launches-retrospective-blood-based-mrd-study-with-university-of-athens-as-part-of-2026-multi-center-validation-program</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-genomics-launches-retrospective-blood-based-mrd-study-with-university-of-athens-as-part-of-2026-multi-center-validation-program</guid>
      <pubDate>Thu, 18 Dec 2025 21:05:00 GMT</pubDate>
      <description>Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB:...</description>
    </item>
    <item>
      <title>Telo Genomics Presents Genomic Profiles of Peripheral Blood Minimal Residual Disease Cells at the 67th American Society of Hematology Meeting</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-genomics-presents-genomic-profiles-of-peripheral-blood-minimal-residual-disease-cells-at-the-67th-american-society-of-hematology-meeting</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-genomics-presents-genomic-profiles-of-peripheral-blood-minimal-residual-disease-cells-at-the-67th-american-society-of-hematology-meeting</guid>
      <pubDate>Thu, 11 Dec 2025 21:00:00 GMT</pubDate>
      <description>Toronto, Ontario--(Newsfile Corp. - December 11, 2025) -  Telo Genomics Corp. (TSXV: TELO) (OTCQB...</description>
    </item>
    <item>
      <title>Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/small-cap-growth-virtual-investor-conference-presentations-now-available-for-online-viewing-3</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/small-cap-growth-virtual-investor-conference-presentations-now-available-for-online-viewing-3</guid>
      <pubDate>Wed, 10 Dec 2025 14:57:30 GMT</pubDate>
      <description>NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary...</description>
    </item>
    <item>
      <title>Small Cap Growth Virtual Investor Conference Agenda Announced for December 9th</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/small-cap-growth-virtual-investor-conference-agenda-announced-for-december-9th-3</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/small-cap-growth-virtual-investor-conference-agenda-announced-for-december-9th-3</guid>
      <pubDate>Wed, 10 Dec 2025 13:35:00 GMT</pubDate>
      <description>NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary...</description>
    </item>
    <item>
      <title>Telo Genomics Corp to Present at the Small Cap Growth&amp;#xA0;Virtual Investor Conference December 9th</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-genomics-corp-to-present-at-the-small-cap-growthandxa0virtual-investor-conference-december-9th</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-genomics-corp-to-present-at-the-small-cap-growthandxa0virtual-investor-conference-december-9th</guid>
      <pubDate>Mon, 08 Dec 2025 13:35:00 GMT</pubDate>
      <description>TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSXV: TELO, OTCQB: TDSGF), based ...</description>
    </item>
    <item>
      <title>Telo Genomics Corp to Present at the Small Cap Growth Virtual Investor Conference December 9th</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-genomics-corp-present-small-133500390</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-genomics-corp-present-small-133500390</guid>
      <pubDate>Mon, 08 Dec 2025 13:35:00 GMT</pubDate>
      <description>Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.comTORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSXV: TELO, OTCQB: TDSGF), based in Toronto, a leader in diagnostic and prognostic innovation through its proprietary multi-factor telomere analytics platform, today announced that Guido Baechler, Executive Chairman, will present live at the Small Cap Growth Virtual Investor Conference hosted by</description>
    </item>
    <item>
      <title>Telo Genomics to Present Groundbreaking Individual-Cell Risk Assessment MRD Technology at the Myeloma Canada MRD Implementation Summit 2025</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-genomics-to-present-groundbreaking-individual-cell-risk-assessment-mrd-technology-at-the-myeloma-canada-mrd-implementation-summit-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-genomics-to-present-groundbreaking-individual-cell-risk-assessment-mrd-technology-at-the-myeloma-canada-mrd-implementation-summit-2025</guid>
      <pubDate>Thu, 13 Nov 2025 13:30:00 GMT</pubDate>
      <description>Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB:...</description>
    </item>
    <item>
      <title>American Society of Hematology Accepts Telo Genomics&apos; Abstract for Presentation at its 2025 Meeting and Exposition</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/american-society-of-hematology-accepts-telo-genomics-abstract-for-presentation-at-its-2025-meeting-and-exposition</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/american-society-of-hematology-accepts-telo-genomics-abstract-for-presentation-at-its-2025-meeting-and-exposition</guid>
      <pubDate>Thu, 09 Oct 2025 12:30:00 GMT</pubDate>
      <description>Recognition highlights commercial potential of Telo&apos;s telomere-based MRD technology in the growin...</description>
    </item>
    <item>
      <title>Telo Genomics Expands Operations with Relocation of Clinical Laboratories to New, Larger Toronto Facility and Provides Board Update</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-genomics-expands-operations-with-relocation-of-clinical-laboratories-to-new-larger-toronto-facility-and-provides-board-update</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-genomics-expands-operations-with-relocation-of-clinical-laboratories-to-new-larger-toronto-facility-and-provides-board-update</guid>
      <pubDate>Tue, 30 Sep 2025 20:30:00 GMT</pubDate>
      <description>Toronto, Ontario--(Newsfile Corp. - September 30, 2025) -  Telo Genomics Corp. (TSXV: TELO) (OTCQ...</description>
    </item>
    <item>
      <title>Telo Genomics Highlights New MRD Methodology at The 2025 International Myeloma Society Meeting</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-genomics-highlights-new-mrd-methodology-at-the-2025-international-myeloma-society-meeting</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-genomics-highlights-new-mrd-methodology-at-the-2025-international-myeloma-society-meeting</guid>
      <pubDate>Fri, 19 Sep 2025 12:30:00 GMT</pubDate>
      <description>Toronto, Ontario--(Newsfile Corp. - September 19, 2025) -  Telo Genomics Corp. (TSXV: TELO) (OTCQ...</description>
    </item>
    <item>
      <title>Telo Geonomics Announces Engagement of Investor Relations Service Provider</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-geonomics-announces-engagement-of-investor-relations-service-provider</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-geonomics-announces-engagement-of-investor-relations-service-provider</guid>
      <pubDate>Mon, 08 Sep 2025 20:20:00 GMT</pubDate>
      <description>Vancouver, British Columbia--(Newsfile Corp. - September 8, 2025) -  Telo Genomics Corp. (TSXV: T...</description>
    </item>
    <item>
      <title>OTCQB Venture Virtual Investor Conference: Presentations Now Available for Online Viewing</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/otcqb-venture-virtual-investor-conference-presentations-now-available-for-online-viewing-3</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/otcqb-venture-virtual-investor-conference-presentations-now-available-for-online-viewing-3</guid>
      <pubDate>Fri, 08 Aug 2025 12:35:00 GMT</pubDate>
      <description>NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary...</description>
    </item>
    <item>
      <title>Telo Genomics to Present at the OTCQB Venture Virtual Investor Conference</title>
      <link>https://6ix.com/company/telo-genomics-corp/news/telo-genomics-to-present-at-the-otcqb-venture-virtual-investor-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/telo-genomics-corp/news/telo-genomics-to-present-at-the-otcqb-venture-virtual-investor-conference</guid>
      <pubDate>Tue, 05 Aug 2025 20:10:00 GMT</pubDate>
      <description>Toronto, Ontario--(Newsfile Corp. - August 5, 2025) -  Telo Genomics Corp. (TSXV: TELO) (OTCQB: T...</description>
    </item>
  </channel>
</rss>